Search

Search Constraints

You searched for: Author/Creator Hasegawa, Takeo

Search Results

1. A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib. Issue 15 (23rd June 2021)

2. Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004). (March 2021)

4. Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles. (21st February 2013)

5. Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma. (5th February 2015)

6. Temperature analysis of aortic repair with hypothermic circulatory arrest to quantify the injury by cooling. Issue 1 (9th January 2023)